CVS Health Corp
Will Walgreens’ Q3 Results Beat Wall Street’s Forecast?
Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.
Walmart to Boost Pharmacy Business with CareZone’s Tech Acquisition
Today, CNBC reported that Walmart (NYSE:WMT) has acquired prescription management technology from CareZone to boost its pharmacy space.
Why Walgreens Stock Fell despite Upbeat Q2 Earnings
Walgreens Boots Alliance (NASDAQ:WBA) reported strong earnings for the second quarter of fiscal 2020. The second quarter ended on February 29.
What to Expect from Walgreens’ Q2 Earnings
Analysts expect Walgreen’s second-quarter sales to rise 2.1% YoY to $35.3 billion. The company is scheduled to release its earnings results on April 2.
Bears Return to Walgreens Stock, Challenges Persist
Walgreens Boots Alliance stock is feeling pressure again. The stock fell about 6% on Wednesday, which reflects its weaker start to fiscal 2020.
Walgreens Posts Disappointing Q1 Earnings Results
Today, Walgreens Boots Alliance reported lower-than-expected results for the first quarter of fiscal 2020. The adjusted EPS fell on a YoY basis.
Can the US Cannabis Market Rescue ACB?
Aurora Cannabis (ACB) stock isn’t in the best shape today. As reported by BNN Bloomberg, the company’s CEO, Terry Booth, is justifiably worried.
CVS Health Stock: What’s Fueling Growth and Will the Uptrend Last?
CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.
Wellington Management: Analyzing Its Top Holdings
Wellington Management filed its 13F on Wednesday. Based on the filing, the market value of total publicly traded securities was around $443.45 billion.
Walgreens: Reports of KKR Buyout Offer, Stock Rose
Walgreens Boots Alliance (WBA) stock rose 5.1% on Monday. Bloomberg reported that private equity firm KKR has formally offered to buy the company.
CVS Keeps Beating Estimates, Raises Earnings Outlook
CVS Health (CVS) again beat analysts’ revenue and EPS estimates when it released its Q3 earnings today. Its stock was up about 3% in premarket trading.
Why Walgreens Is Mulling Over Going Private
Reuters reports that Walgreens Boots Alliance (WBA) is exploring options to go private and has engaged Evercore Partners to put together a deal.
Why CVS Stock Looks Strong Ahead of Q3 Earnings
CVS Health (CVS) is slated to announce its third-quarter earnings results tomorrow. We believe the company sustained its sales momentum in the quarter.
Walgreens Stock: Q4 Beat Might Not Spur Recovery
Walgreens Boots Alliance (WBA) struggled in fiscal 2019. Sales headwinds and pressure on margins from reimbursements dragged the stock down.
Walgreens Stock: What to Expect from Its Q4 Earnings
Walgreens is scheduled to report its fourth-quarter earnings before the markets open on October 28. We expected a limited downside in Walgreens stock.
Walgreens Stock Fizzles after Brief Recovery
Pressure on Walgreens (WBA) stock had started easing a bit. However, the revival was short lived, and WBA fell about 2% last week.
Walgreens Stock: Deutsche Bank Recommends a ‘Sell’
Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news.
Why Walgreens Stock Underperformed CVS in August
Walgreens Boots Alliance (WBA) stock underperformed CVS Health (CVS) stock last month, with Walgreens falling 6% and CVS rising about 9%.
Why Has Curaleaf Lost 13.5% in August?
As of August 17, Curaleaf Holdings (CURA) (CURLF) was trading at 9.00 Canadian dollars—a fall of 13.5% in August.
Charlotte’s Web Holdings Stock Down after Earnings
Charlotte’s Web Holdings stock (CWBHF)(CWEB) was down 6.6% yesterday after the company reported lower-than-expected Q2 earning results.
Walgreens or CVS Stock: Which Is a Better Value Buy?
Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.
CVS Beats Q2 Estimates by a Wide Margin
CVS Health (CVS) announced better-than-expected second-quarter results on Wednesday. The company sustained the first-quarter momentum.
Walgreens Will Close 200 US Stores
In a regulatory filing on Tuesday, Walgreens Boots Alliance (WBA) announced that it will close 200 stores in the US to focus on store optimization.
Amazon Stock: Does the Recent Slide Indicate a Buy?
Amazon (AMZN) stock has fallen more than 10% since the company reported mixed second-quarter results. The stock fell 3.2% on Monday.
Could CVS Health’s Q2 Results Boost Its Stock?
CVS Health (CVS) is set to announce its second-quarter results on August 7. We expect CVS to sustain its momentum in the quarter, supporting its stock.
Align Technology Stock Recovers after Tanking Last Week
Align Technology stock (ALGN) took a massive hit after Q2 earnings. So what was behind the massive decline, and what’s helping the stock recover?
Amazon Suffers a Blow in Talent Row with CVS Health
Amazon’s (AMZN) efforts to crack the more than $600 billion prescription drug market in the US has suffered a blow, albeit a mild one. A federal judge in Rhode Island ruled on June 18 that a former executive at pharmacy chain CVS Health (CVS) couldn’t work for Amazon’s pharmacy business, PillPack.
CVS Health Stock: Analysts’ Suggestions
CVS Health’s top line is expected to grow at a healthy double-digit rate in the near term due to the Aetna acquisition.
Is CVS Stock Too Cheap to Ignore?
CVS Health (CVS) has fallen 18.5% on a YTD (year-to-date) basis as of June 3. CVS Health’s bottom line is expected to fall in the near term.
Will Pressure on Earnings Limit the Upside in CVS Health Stock?
CVS Health (CVS) impressed investors with its first-quarter sales and earnings.
CVS Health Stock Rises 5.4% on Strong First-Quarter Earnings
CVS Health (CVS) stock jumped 5.4% on May 1 on stronger-than-expected first-quarter results.
How Analysts Rate CVS Stock
CVS Health (CVS) stock is trading at 7.8x its 2019 estimated EPS of $6.79.
What to Expect from CVS Health’s First-Quarter Results
CVS Health (CVS) plans to announce its first-quarter results on Wednesday, May 1.
What Analyst Ratings Indicate for CVS Stock
Among the 27 analysts covering CVS Health (CVS) stock, 18 analysts suggest a “buy,” and nine analysts recommend a “hold.”
Oppenheimer Downgrades CVS Health Stock to ‘Perform’
On April 15, Oppenheimer downgraded CVS Health (CVS) stock to “perform” from “outperform.”
Pharmaceutical Retailers Underperformed Broader Markets
CVS and Walgreens stock fell 17.7% and 7.4%, respectively, in the first quarter, which reflected the weak earnings outlook.
Consumer Staples Stocks: Stragglers in Q1
Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.
What’s the Potential Upside in CVS and WBA Stock?
Analysts maintain a positive outlook on CVS Health (CVS) stock.
Are CVS and Walgreens Stock Too Cheap to Ignore?
CVS Health (CVS) is down 19.4% on a YTD basis as of April 3.
What Analysts Recommend for Walgreens after Q2
Most analysts maintain a “hold” rating on Walgreens Boot Alliance (WBA) stock.
What Affected Walgreens’s Q2 EPS?
Walgreens Boots Alliance (WBA) posted adjusted earnings of $1.64 per share, a 5.4% decrease on a YoY basis.
Why Walgreens Missed Analysts’ Sales Estimate in Q2
Walgreens Boots Alliance’s (WBA) second-quarter sales of $34.5 billion increased 4.6% on a YoY basis.
Walgreens Stock Fell ~13% on Weak Q2 and Lower Guidance
Walgreens Boots Alliance (WBA) stock dropped 12.8% on Tuesday, April 2.
What’s in the Offing for Walgreens Stock?
Walgreens Boot Alliance disappointed with weaker-than-expected earnings results for the second quarter of fiscal 2019 on April 2.
Walgreens’ Weak Q2 Results Weigh on Its Stock
Walgreens Boots Alliance (WBA) reported dismal results for the second quarter of fiscal 2019 on April 2.
Walgreens Stock: Why Analysts Lowered the Target Price
Analysts lowered their target price on Walgreens Boot Alliance (WBA) stock. On March 27, Cowen lowered its target price to $66 from $75.
Amazon Challenges Walgreens and CVS Health Again
Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.
What Drove Curaleaf’s Stock Price Last Week?
On March 22, the US market fell on concerns over global growth prospects as the long-term bond yield fell below the short-term yield.
Walgreens Stock Continues to Fall Due to Multiple Price Cuts
Walgreens Boot Alliance (WBA) shares have taken a beating the past few days. Multiple analysts lowered their target price on the stock.
Walgreens and CVS Stocks Look Attractive despite Challenges
Walgreens Boots Alliance (WBA) and CVS Health (CVS) shares have taken a beating. Bottom-line challenges spooked investors.
What’s Hurting CVS and Walgreens Stocks?
Walgreens Boots Alliance stock (WBA) fell 6.4% on March 1 after Baird’s reduction in target price.
Moat Index: Dramatic Sector Allocation Shift in 2018
The healthcare sector dominated the sector weighting for the Morningstar Wide Moat Index in 2018. The sector returned ~5% in 2018.
Will Walgreens’s Strategic Initiatives Boost Its Sales?
Walgreens Boots Alliance’s (WBA) sales rose 9.9% to $33.8 billion in the first quarter of fiscal 2019 (which ended on November 30, 2018).
How Is Walgreens Boots Alliance Positioned in 2019?
As of January 18, Walgreens Boots Alliance (WBA) stock has risen 6.0% since the start of 2019.
Why Walgreens Stock Fell despite Beating Estimates
Walgreens Boots Alliance (WBA) posted better-than-expected first-quarter results on Thursday, December 20.
Apple Pay Transactions Rose Significantly in Q4 of Fiscal 2018
Apple’s (AAPL) Services segment revenue rose 17% YoY to almost $10 billion in the fourth quarter of fiscal 2018.
CVS: Analysts’ Ratings and Target Prices
CVS Health posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock.
CVS’s Q3 Sales Beat the Estimate
CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion.
CVS Stock Rose 5.7% Due to Strong Third-Quarter Results
CVS reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates.
How Investors Reacted to Walgreens’s Fourth-Quarter Results
Walgreens stock has fallen 2.4% YTD (year-to-date). It fell ~10% after Amazon announced the acquisition of Pillpack in June.
CVS Gets Department of Justice Approval for Aetna Deal
On October 10, the US Department of Justice gave preliminary approval to the $69 billion deal between CVS Health (CVS) and Aetna (AET).
Analyst Ratings for UnitedHealth before Q3 2018 Earnings
Of the 24 analysts covering UNH stock, ten have recommended a “strong buy,” and 13 have recommended a “buy.”
Comcast Is Selling Bonds to Fund the Sky Acquisition
As of October 2, Comcast (CMCSA) has sold unsecured bonds worth $27 billion to finance its $38.8 billion purchase of 61% of Sky.
Walgreens Stock Rises as RBC Increases Price Target 20%
RBC Capital Markets raised the price target for Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8.
Walgreens’s EPS to Rise 11% in Q4 2018
Wall Street expects a 10.7% year-over-year jump in Walgreens Boots Alliance’s (WBA) EPS to $1.45 during the fourth quarter of fiscal 2018.
Rite Aid Reports in-Line EPS in the Second Quarter
Rite Aid (RAD) reported a second-quarter adjusted net loss from continuing operations of $7.9 million or $0.01 loss per share.
Rite Aid Finally Posts Top-Line Growth in the Second Quarter
Rite Aid (RAD) reported results for the second quarter—which ended on September 1—yesterday. The company’s top line from continuing operations improved 1.4 % YoY (year-over-year) to $5.42 billion.
After Two Failed Mergers, Where Does Rite Aid Stand Now?
Struggling with the company’s financial position, Rite Aid’s management has tried to sell the company’s assets since 2015.
Estimates and Recommendations for DaVita on September 17
Analysts estimate that DaVita (DVA) will report a 25.3% decline in revenues to $11.6 billion in 2018 compared to $15.5 billion in 2017.
Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price
CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.
CVS Health’s Analyst Ratings Have Improved in 2018
CVS was upgraded by Citigroup from “neutral” to “buy” on July 9.
Novartis’s Q2 2018 Earnings: Sandoz
Sandoz, the generics arm of Novartis (NVS), reported nearly flat revenues at ~$2.46 billion during Q2 2018.
How Pharmacies and Drugstores Are Defending against Amazon
Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.
Here’s Why Walgreens Stock Crashed despite Strong Q3 Results
After Walgreens announced its fiscal Q3 results, Amazon announced its plan to acquire PillPack, an online pharmacy company, and WBA stock crashed.
Walgreens Reports 14% Sales Growth in Fiscal Third Quarter
Walgreens’s fiscal third-quarter top line increased 14% YoY to $34.3 billion. On a constant currency basis, sales rose 11.8% YoY.
Rite Aid’s Fiscal Q1 2019 Beat Drives Its Stock After Hours
Rite Aid’s (RAD) better-than-expected results drove its stock by 1.5% in the post-trading session on June 27.
Discussing Rite Aid’s Fiscal Q1 2019 Margins
Rite Aid (RAD) reported adjusted net income from continuing operations of -$11.5 million, or -$0.01 per share, in the fiscal first quarter of 2019.
Analysts Aren’t So Sure about Rite Aid Stock
After a disastrous 2017, Rite Aid stock has managed to stay in the green so far this year.
What’s behind Rite Aid’s Deteriorating Margins?
Rite Aid has witnessed a continuous deterioration in its profitability over the years.
CVS Health Launches Prescription Delivery Service, Stock Jumps ~5%
Today, CVS Health, the leading pharmacy benefit managers, is up ~5% after announcing the launch of its drug delivery service from all of its US locations.
S&P 500’s Top Losses: Why Biogen Declined
Biogen, which is an American multinational biotechnology company, was the S&P 500’s top loss on June 18.
Why Envision Healthcare Stock Rose ~2.4% Last Week
Healthcare service provider Envision Healthcare (EVHC) announced its agreement to be acquired by KKR (KKR) last week.
What’s the Dividend Yield of the Consumer Non-Cyclical Sector?
The consumer non-cyclical segment recorded a dividend yield of 3%.
Analysts’ Take on CVS Health and Walgreens
Walgreens Boots Alliance and CVS Health are both well-covered stocks. While Walgreens is tracked by 27 analysts, 25 analysts cover CVS.
CVS Health and Walgreens: Financial Health
CVS recorded total sales of $186 billion (+4% YoY) in the last 12 months. The Pharmacy Services segment was the company’s biggest moneymaker.
CVS Health versus Walgreens: Comparing Pharmacy Giants
Around 70% of the US population lives within three miles of a CVS store, while more than 75% of the population lives within five miles of a Walgreens store.
Drugstore Stocks Tumble ahead of Trump’s New Drug Policy
The stocks of top drugstore chains CVS Health (CVS) and Walgreens Boots Alliance (WBA) were down yesterday amid ongoing tensions regarding a policy change in US drug pricing.
A Quick Overview of CVS Health’s 1Q18 Profitability
While CVS Health (CVS) fumbled with its 1Q18 top-line expectations, it still managed to cruise ahead of Wall Street’s bottom-line forecasts.
Recommendations for UNH Stock after Its 1Q18 Results: All ‘Buy’
Of the 22 analysts tracking UNH stock on April 19, 50% rated it as a “strong buy,” and the remaining 50% of these analysts rated the company as a “buy.”
Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18
Rite Aid’s (RAD) top line for fiscal 4Q18 fell 8.6% YoY to $5.4 billion, missing the average consensus expectation by $180 million.
How Is UNH’s Optum Business Positioned in the Industry?
UnitedHealth Group is, by revenue, the largest healthcare company in the world.
Analysts’ Recommendations for UnitedHealth Group
UnitedHealth Group is the world’s largest healthcare company in terms of revenue. In fiscal 2017, it generated revenue of $201 billion.
Why Goldman Sachs Has Positive Views on CVS Health
Goldman Sachs (GS) also included CVS Health (CVS) in its domestic stock pick list.
Top Gainers in the Consumer Sector Last Week
Florida-based Lennar (LEN) released its fiscal 1Q18 results on April 4, 2018.
How Wall Street Views Rite Aid Stock ahead of 4Q18 Results
Rite Aid’s stock has plunged around 18% this year after falling 76% last year.
Walmart Eyes Growth Avenues—Healthcare Could Be One
CNBC has reported that Walmart is looking to acquire PillPack, an online pharmacy startup, for less than $1 billion.
No Recommendation Changes after Walgreens Releases 2Q18 Results
Walgreens Boots Alliance (WBA) stock rose 3.1% after it reported better-than-expected results on March 28, 2018.
Could Walgreens Exceed Expectations Again in 2Q18?
Wall Street has projected a strong quarter for Walgreens Boots Alliance (WBA) in 2Q18, projecting a 14% YoY (year-over-year) increase in its EPS (earnings per share).
SuperValu Has Decided to Sell Farm Fresh
SuperValu (SVU) announced on March 14 that it’s selling 21 of its 38 Farm Fresh stores to three grocery store chains.
What’s LHC Group’s Business Strategy?
In 2018, LHC Group is expected to report revenue of $1.2 billion. What about its peers?